In March 2025, the company declared new options for the direct-to-shopper providing of its Wegovy weight loss drug. The company recognized a new pharmacy, referred to as NovoCare, which would demand clients $499 a month for usage of the drug, a lot less than half the expense of the drug via other pharmaceutical distribution networks.[53]This led No